NAGLAZYME Trademark

Trademark Overview

On Friday, May 13, 2005, a trademark application was filed for NAGLAZYME with the United States Patent and Trademark Office. The USPTO has given the NAGLAZYME trademark a serial number of 78629370. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, September 28, 2015. This trademark is owned by BioMarin Pharmaceutical Inc.. The NAGLAZYME trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely pharmaceuticals for use in treatment of lysosomal storage disorders
naglazyme

General Information

Serial Number78629370
Word MarkNAGLAZYME
Filing DateFriday, May 13, 2005
Status800 - REGISTERED AND RENEWED
Status DateMonday, September 28, 2015
Registration Number3132316
Registration DateTuesday, August 22, 2006
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 21, 2006

Trademark Statements

Goods and Servicespharmaceutical preparations, namely pharmaceuticals for use in treatment of lysosomal storage disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 20, 2005
Primary Code005
First Use Anywhere DateWednesday, June 8, 2005
First Use In Commerce DateWednesday, June 8, 2005

Trademark Owner History

Party NameBioMarin Pharmaceutical Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameBioMarin Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameBioMarin Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events

Event DateEvent Description
Friday, May 20, 2005NEW APPLICATION ENTERED
Saturday, December 10, 2005ASSIGNED TO EXAMINER
Wednesday, December 14, 2005EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 14, 2005EXAMINER'S AMENDMENT ENTERED
Wednesday, December 14, 2005USE AMENDMENT FILED
Wednesday, December 14, 2005AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, December 14, 2005USE AMENDMENT ACCEPTED
Thursday, December 15, 2005CORRESPONDENCE MAILED
Friday, December 16, 2005ASSIGNED TO LIE
Monday, January 9, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 2, 2005TEAS AMENDMENT OF USE RECEIVED
Wednesday, December 14, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 14, 2005PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, December 14, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 17, 2006EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, July 7, 2006EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, August 22, 2006REGISTERED-PRINCIPAL REGISTER
Wednesday, April 4, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, April 5, 2012REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, April 5, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, February 1, 2006NOTICE OF PUBLICATION
Tuesday, February 21, 2006PUBLISHED FOR OPPOSITION
Tuesday, March 6, 2012TEAS SECTION 8 & 15 RECEIVED
Saturday, August 22, 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, September 28, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, August 22, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, September 28, 2015REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, August 28, 2015TEAS SECTION 8 & 9 RECEIVED
Monday, September 28, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 28, 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Related Keywords

naglazyme lysosomal storage disorders treatment pharmaceuticals preparations namely pharmaceutical